SIX Swiss Exchange · Healthcare
Invest in Medacta stock from India
Indian and foreign residents can buy Medacta (MOVE) shares directly through Paasa.
By Paasa · Updated
Medacta at a glance
- Price
- CHF 115.20-CHF 0.20 (0.17%)
- Market cap
- CHF 2.29B
- Day range
- CHF 114.80 – CHF 117.20
- P/E
- 31.27
- Dividend yield
- 0.95%
- Volume
- 6.34K
- 1 month
- -8.86%
- 6 months
- -22.58%
- YTD
- -26.34%
- 1 year
- -20.99%
- 5 years
- -20.77%
Medacta statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €688.3M | €590.6M | €510.8M | €437.1M | €363.1M |
| Gross profit | €441.4M | €399.4M | €347.8M | €305.3M | €261.2M |
| Operating income | €115.7M | €90.8M | €74.4M | €61.5M | €58.8M |
| Net income | €96.1M | €72.9M | €47.4M | €46.2M | €51.5M |
| Earnings per share | €4.81 | €3.65 | €2.37 | €2.32 | €2.58 |
| EBITDA | €190.6M | €160.5M | €119.6M | €107.0M | €97.8M |
| Total assets | €916.9M | €792.2M | €695.9M | €584.5M | €489.3M |
| Total debt | €262.6M | €241.2M | €202.0M | €170.2M | €132.7M |
| Cash and short-term investments | €33.2M | €31.6M | €20.8M | €32.3M | €20.4M |
| Shareholders' equity | €456.2M | €379.7M | €330.0M | €274.7M | €226.4M |
| Operating cash flow | €153.7M | €107.1M | €75.1M | €73.5M | €54.1M |
| Free cash flow | €29.9M | €2.5M | −€7.1M | €10.4M | €7.6M |
| Capital expenditure | −€123.8M | −€104.7M | −€82.2M | −€63.2M | −€46.5M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Ypsomed | YPSN.SW | CHF 363.60 | CHF 4.78B |
| Galenica | GALE.SW | CHF 82.90 | CHF 4.13B |
| Siegfried | SFZN.SW | CHF 73.50 | CHF 3.22B |
| Tecan | TECN.SW | CHF 233.20 | CHF 2.95B |
| BB Biotech | BION.SW | CHF 51.00 | CHF 2.81B |
| SKAN | SKAN.SW | CHF 69.50 | CHF 1.56B |
| Aevis Victoria | AEVS.SW | CHF 15.75 | CHF 1.33B |
| Medartis | MED.SW | CHF 85.20 | CHF 1.06B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Medacta from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to CHF when you buy.
Step 3
Search MOVE and buy
Find Medacta by name or by its ticker, MOVE, and place your order.
Why invest in Medacta from India
What Medacta does
Medacta Group S.A. is a worldwide enterprise specializing in the design, production, and distribution of medical devices for both orthopedic and neurosurgical applications. Operating across Europe, North America, the Asia-Pacific region, and numerous other international markets, the company delivers specialized solutions. Medacta operates in the Medical - Specialties industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Medacta stock from India?
Yes. Indian residents and NRIs can buy Medacta (MOVE) shares directly through Paasa. Medacta is listed on the SIX Swiss Exchange, in the Medical - Specialties industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Medacta shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the CHF/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.